MEDEINOS VAISTINĖ - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 607,037 | 620,154 | 709,694 | 662,176 | 608,780 | 562,745 | 560,150 | 147,183 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 12,308 | 18,657 | 40,218 | 7,522 | 2,178 | -19,089 | 12,688 | -55,142 |
| Equity | 82,838 | 105,225 | 107,715 | 92,238 | 94,417 | 75,326 | 88,014 | 32,826 |
| Liabilities | 36,562 | 30,297 | 32,417 | 28,964 | 27,479 | 56,006 | 49,620 | 1,180 |
| Non-current assets | 27,859 | 46,008 | 39,963 | 32,698 | 25,612 | 18,576 | 207 | 9 |
| Current assets | 91,541 | 89,514 | 100,169 | 88,504 | 96,284 | 112,756 | 136,952 | 33,757 |
| Total assets | 119,400 | 135,522 | 140,132 | 121,202 | 121,896 | 131,332 | 137,159 | 33,766 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 34,157 | 38,950 | 27,207 |
| Social insurance contributions | - | - | - | - | - | 24,438 | 23,604 | 8,622 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -1.8% | +2.2% | +14.4% | -6.7% | -8.1% | -7.6% | -0.5% | -73.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 10.3% | 13.8% | 28.7% | 6.2% | 1.8% | -14.5% | 9.3% | -163.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 14.9% | 17.7% | 37.3% | 8.2% | 2.3% | -25.3% | 14.4% | -168.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.0% | 3.0% | 5.7% | 1.1% | 0.4% | -3.4% | 2.3% | -37.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.7 | 0.6 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 104,064 | 124,031 | 166,987 | 165,544 | 152,195 | 140,686 | 140,038 | 76,790 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDEINOS VAISTINĖ - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-11-16 | 2021-11-17 | 0.27 |
| 2021-11-05 | 2021-11-07 | 0.27 |
MEDEINOS VAISTINĖ - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-10-10 | 2024-10-16 | 1.82 |
| 2024-10-04 | 2024-10-09 | 452.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDEINOS VAISTINE, UAB (code 123906692) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, revenue fell to €147.2K from €560.1K in 2024, a decline of 73.7% year on year, while the company moved from a €12.7K profit in 2024 to a net loss of €55.1K in 2025. The 2025 profit margin was -37.5%, reflecting weaker operating performance after a positive result a year earlier. Over the three-year period, revenue was broadly stable between 2023 and 2024, before dropping sharply in 2025; net profit also moved from a loss in 2023 to profit in 2024 and back to a larger loss in 2025. At the end of 2025, total assets were €33.8K, equity €32.8K and liabilities €1.2K. The equity ratio was 97.2% and debt-to-equity 0.04, indicating a very low leverage position despite the reduced balance sheet size. Asset turnover reached 4.36x, and revenue per employee was €147.2K in 2025.